OVARIEN TUMORS

Abstract

Malignant ovarian tumors account for 4% of all cancers and the leading cause of gynecological cancer death in the world. We conducted a retrospective study over a period of 30 months in the gynecology department of Sheikh Zayed Hospital in Nouakchott, the study population consisted of all patients operated for a malignant tumor of ovary during the study period. The average age was 48 years with extremists from 18 years to 78 years , the fiGO stage was specified in 48 cases or 96% of the cases , stage I 3 cases (6%) ,stage II 2 cases (4%), stage III 29 cases (58%), stage IV 14 cases (28%). Surgery was performed in all patients in a conventional manner (xiphoid median laparotomy), the progression was marked by the occurrence of 24 deaths (48%) ,16 live without recurrence (32%)), 4 patients with recurrence (8%) and 6 patients lost sight (12%). Survival over a 30-month period averaged 10.23 months with a minimum of 0 days and a maximum of 30 months. Ovarian cancer is discovered at a late stage from which the prognosis is often bleak. Surgical treatment remains the basic treatment for ovarian tumors.